276 related articles for article (PubMed ID: 28649660)
1. How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Crew KD; Albain KS; Hershman DL; Unger JM; Lo SS
NPJ Breast Cancer; 2017; 3():20. PubMed ID: 28649660
[TBL] [Abstract][Full Text] [Related]
2. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
Crew KD
Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention for Breast Cancer.
Pruthi S; Heisey RE; Bevers TB
Ann Surg Oncol; 2015 Oct; 22(10):3230-5. PubMed ID: 26202562
[TBL] [Abstract][Full Text] [Related]
5. Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study.
Karavites LC; Allu S; Khan SA; Kaiser K
BMC Cancer; 2015 Nov; 15():878. PubMed ID: 26552376
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of breast cancer in the older patient.
Minton SE
Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
Levine M; Moutquin JM; Walton R; Feightner J;
CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in breast cancer chemoprevention.
Chlebowski RT
Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912
[TBL] [Abstract][Full Text] [Related]
9. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Tseng CW; Wong JB
JAMA; 2019 Sep; 322(9):857-867. PubMed ID: 31479144
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.
Ball S; Arevalo M; Juarez E; Payne JD; Jones C
Prev Med; 2019 Dec; 129():105834. PubMed ID: 31494144
[TBL] [Abstract][Full Text] [Related]
11. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Jordan VC; Brodie AM
Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention for high-risk women: tamoxifen and beyond.
Fabian CJ; Kimler BF
Breast J; 2001; 7(5):311-20. PubMed ID: 11906441
[TBL] [Abstract][Full Text] [Related]
13. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
Fabian CJ; Kimler BF
Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
[TBL] [Abstract][Full Text] [Related]
15. Progress in chemoprevention of breast cancer.
Serrano D; Perego E; Costa A; Decensi A
Crit Rev Oncol Hematol; 2004 Feb; 49(2):109-17. PubMed ID: 15012972
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention for breast cancer: overcoming barriers to treatment.
Brewster AM; Davidson NE; McCaskill-Stevens W
Am Soc Clin Oncol Educ Book; 2012; ():85-90. PubMed ID: 24451714
[TBL] [Abstract][Full Text] [Related]
17. Physician and Patient Barriers to Breast Cancer Preventive Therapy.
Hum S; Wu M; Pruthi S; Heisey R
Curr Breast Cancer Rep; 2016; 8(3):158-164. PubMed ID: 27617055
[TBL] [Abstract][Full Text] [Related]
18. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
Howell A; Howell SJ; Clarke R; Anderson E
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors: rationale and use in breast cancer.
Osborne C; Tripathy D
Annu Rev Med; 2005; 56():103-16. PubMed ID: 15660504
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
